1stOncology™: Cancer Intelligence Service – Page 15462 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Avid Bioservices to Present at the 30th Annual ROTH Conference

On March 6, 2018 Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, reported that its president and chief executive officer, Roger J. Lias, Ph.D., will deliver a corporate presentation at the 30th Annual ROTH Conference (Press release, Avid Bioservices, MAR 6, 2018, View Source [SID1234524436]). The conference is being held March 11-14, 2018 at the Ritz-Carlton Laguna Niguel in Dana Point, CA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Details of this presentation are as follows:

30th Annual ROTH Conference
Time/Date: 2:00 p.m. PT on Tuesday, March 13, 2018
Location: Ritz-Carlton Laguna Niguel, Dana Point, CA
Room: Yellow Salon 6
Avid’s presentation at the ROTH conference will be webcast live and available for replay at: View Source

Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference

On March 6, 2018 Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, reported that Isaac Ciechanover, M.D., the Company’s President and Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference on Tuesday, March 13, 2018 at 8:00 a.m. EDT (Press release, Atara Biotherapeutics, MAR 6, 2018, http://investors.atarabio.com/news-releases/news-release-details/atara-biotherapeutics-present-cowen-and-company-38th-annual [SID1234524435]). The conference will be held at the Boston Marriott Copley Place Hotel in Boston, MA.

A live audio webcast of the presentation will be available by visiting the Investors section of the Atara website at www.atarabio.com. An archived replay of the webcast will be available on the Company’s website for 14 days following the presentation.

Aptose to Participate in Upcoming Investor Conferences In March 2018

On March 6, 2018 Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, reported that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming conferences (Press release, Aptose Biosciences, MAR 6, 2018, View Source;p=RssLanding&cat=news&id=2336407 [SID1234524433]):

Cowen and Company 38th Annual Healthcare Conference
Time: 12:00 p.m. EDT
Date: Monday, March 12, 2018
Location: The Boston Marriott Copley Place, Boston, MA
Live webcast: http://wsw.com/webcast/cowen46/apto/

30th Annual ROTH Conference
Time: 9:30 a.m. PDT
Date: Tuesday, March 13, 2018
Location: The Ritz Carlton, Laguna Niguel, CA
Live webcast: View Source

2018 B. Riley & Co. China Healthcare Investment Partnering Symposium
Time: 11:30 a.m. CST (China Standard Time)
Date: Friday, March 16, 2018
Location: The Intercontinental Hotel, Hangzhou, People’s Republic of China
Live webcast: View Source

Oppenheimer 28th Annual Healthcare Conference
Time: 8:00 a.m. EDT
Date: Wednesday, March 21, 2018
Location: The Westin Grand Central, New York, NY
Live webcast: https://veracast.com/webcasts/opco/healthcare2018/76201109497.cfm

The audio webcasts can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live event and available for 90 days.

Altimmune to Participate at Two Investor Conferences in March

On March 6, 2018 Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, reported that Bill Enright, President and Chief Executive Officer, will provide a corporate overview at the 30th Annual ROTH Conference and the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (Press release, Altimmune, MAR 6, 2018, View Source [SID1234524432]).

30th Annual ROTH Conference Presentation Details
Date: Tuesday, March 13
Time: 7:00pm Eastern Time/4:00pm Pacific Time
Location: The Ritz Carlton Orange County, Newport Beach, California – Salon 6

B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS)
Date: Saturday, March 17
Time: 8:30am China Time/7:30pm Eastern Time – Room A
Location: Intercontinental Hotel, Hangzhou, China

TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2017 Financial Results and Business Update

On March 6, 2018 TG Therapeutics, Inc. (NASDAQ:TGTX), reported that a conference call will be held on Thursday March 8, 2018 to discuss results for the fourth quarter and year-end 2017, and provide a business outlook for 2018 (Press release, TG Therapeutics, MAR 6, 2018, View Source [SID1234524423]). Michael S. Weiss, Executive Chairman and Chief Executive Officer, will host the call.

In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Year-End 2017 Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at www.tgtherapeutics.com. An audio recording of the conference call will also be available for replay at www.tgtherapeutics.com, for a period of 30 days after the call.

TG Therapeutics will announce its financial results for this period in a press release to be issued prior to the call.